Our Science – CCRNP Website

CCR Nanobiology Program

Selected News Items

Scientists Find Antibody that Can Potently Neutralize Two Viruses

Web Site: http://www.cancer.gov/newscenter/pressreleases/Henipavirus

CCR Press Release - 02/15/2008

Researchers Identify Novel Type of Antibody that Potently Inhibits HIV Infection

Web Site: http://www.cancer.gov/newscenter/pressreleases/HIVDomainAbDimitrov

CCR Press Release - 10/20/2008

The 1st Joint U.S.-China Symposium on Nanobiology and Nanomedicine - October 21-23, 2008

Web Site: http://www.china-us-nanobiomed-conf.org/

The idea for this exciting collaboration originated in generative scientific exchanges between Dr. Xing-Jie Liang, Director, Nano-Medicine and Nano-Biotechnology Laboratory at the National Center for Nanoscience and Technology, in Beijing, China, and Dr. Robert Blumenthal, Director of the Center for Cancer Research Nanobiology Program, National Cancer Institute, National Institutes of Health, in Frederick, Maryland, U.S.A. Together, Drs. Liang and Blumenthal helped developed the vision for this trans-national symposium, secured support and established a Steering Committee of senior Chinese and U.S. scientists.

The National Institutes of Health (NIH) and the Trans-NIH Nanotechnology Task Force, co-sponsored the first Joint U.S.-China Symposium on Nanobiotechnology and Nanomedicine, in Beijing on October 21-23, 2008. The goal was to develop and apply nanotechnology to prevent, detect, diagnose and treat disease, and to consider the effect of exposure to nanomaterials on workers, the general public and the environment. The initial dialogue comprised an important first step in sharing information, scientific brainstorming, and the development of mutually productive collaborations and working relationships between Chinese and American scientists. This activity fell under the Science & Technology bilateral agreement between the U.S. and China.

CCRNP Award Recipients - Dr. Julie Belanger and Dr. Weizao Chen

Drs. Belanger and Chen both received a Fellows Award for Research Excellence (FARE) from the NIH Fellows Committee. This award, to be used for travel to a national meeting, is based on the quality of the abstract describing their research project. Applicants for FARE awards come from all NIH institutes.

CCRNP Award Recipient - Dr. Robert Blumenthal

Dr. Blumenthal, Director of the Cancer for Cancer Research Nanobiology Program, Center for Cancer Research, NCI is the 2008 recipient of the NIH Merit Award. This award recognizes individuals or groups whose achievements warrant special recognition. Dr. Blumenthal received this award in recognition of his vision and leadership in establishing the CCR Nanobiology Program, which promotes multidisciplinary research in cancer, AIDS, and viral diseases.

Dr. Blumenthal was also nominated for the 2008 NCI Outstanding Mentor Award and was selected as a 'Mentor of Merit.'

These awards were presented at the NCI Director Awards Ceremony on November 4, 2008.

4th Annual Cancer Nanobiology Thank Tank: The Emerging Role of RNA in Nanobiology and Drug Design - May 12, 2009

The Center for Cancer Research Nanobiology Program announces the 4th Annual Cancer Nanobiology Think Tank, to be held at NCI-Frederick in Frederick, Maryland. Registration information will be announced at a later date

This page was last updated on 12/23/2008.